nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—CES2—Phase I biotransformations, non P450—ESD—ocular cancer	0.54	0.54	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—CDKN2C—ocular cancer	0.0341	0.0341	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—E2F5—ocular cancer	0.0284	0.0284	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—E2F4—ocular cancer	0.0278	0.0278	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—MYBL2—ocular cancer	0.0278	0.0278	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—RBL1—ocular cancer	0.0272	0.0272	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—E2F2—ocular cancer	0.0272	0.0272	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—RBL2—ocular cancer	0.025	0.025	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—E2F3—ocular cancer	0.0236	0.0236	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—RBBP4—ocular cancer	0.0236	0.0236	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—CDC25A—ocular cancer	0.0225	0.0225	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—TFDP1—ocular cancer	0.022	0.022	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—CCND3—ocular cancer	0.0199	0.0199	CbGpPWpGaD
Prasugrel—P2RY12—Signal amplification—GNA11—ocular cancer	0.0175	0.0175	CbGpPWpGaD
Prasugrel—P2RY12—Signal amplification—GNAQ—ocular cancer	0.0163	0.0163	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—HDAC1—ocular cancer	0.0128	0.0128	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—E2F1—ocular cancer	0.0105	0.0105	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—CDK2—ocular cancer	0.00905	0.00905	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—RB1—ocular cancer	0.00744	0.00744	CbGpPWpGaD
Prasugrel—CES2—Fluoropyrimidine Activity—TP53—ocular cancer	0.00687	0.00687	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—CDKN1B—ocular cancer	0.00579	0.00579	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—CDKN1A—ocular cancer	0.00534	0.00534	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—EP300—ocular cancer	0.00509	0.00509	CbGpPWpGaD
Prasugrel—CES2—E2F transcription factor network—MYC—ocular cancer	0.00443	0.00443	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.00364	0.00364	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.00338	0.00338	CbGpPWpGaD
Prasugrel—CES2—NRF2 pathway—TGFB1—ocular cancer	0.00254	0.00254	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—GNA11—ocular cancer	0.00188	0.00188	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—GNAQ—ocular cancer	0.00174	0.00174	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—HDAC1—ocular cancer	0.00157	0.00157	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SAG—ocular cancer	0.00134	0.00134	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—GNA11—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—E2F5—ocular cancer	0.00119	0.00119	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—E2F4—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—RBL1—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—CDK2—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—GNAQ—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—GNA11—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—GNAQ—ocular cancer	0.001	0.001	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—E2F3—ocular cancer	0.000987	0.000987	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TFDP1—ocular cancer	0.000918	0.000918	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.000904	0.000904	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.00084	0.00084	CbGpPWpGaD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000735	0.000735	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MAML2—ocular cancer	0.000729	0.000729	CbGpPWpGaD
Prasugrel—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000714	0.000714	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PSPH—ocular cancer	0.000713	0.000713	CbGpPWpGaD
Prasugrel—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.000664	0.000664	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—GNA11—ocular cancer	0.000636	0.000636	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—EP300—ocular cancer	0.000627	0.000627	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PSPH—ocular cancer	0.0006	0.0006	CbGpPWpGaD
Prasugrel—ALB—Platelet degranulation—TGFB1—ocular cancer	0.000592	0.000592	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—GNAQ—ocular cancer	0.000592	0.000592	CbGpPWpGaD
Prasugrel—ALB—Folate Metabolism—TP53—ocular cancer	0.000568	0.000568	CbGpPWpGaD
Prasugrel—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	0.000564	0.000564	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—TGFB1—ocular cancer	0.000545	0.000545	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PSPH—ocular cancer	0.000539	0.000539	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HDAC1—ocular cancer	0.000533	0.000533	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PSPH—ocular cancer	0.000491	0.000491	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CDKN2B—ocular cancer	0.000478	0.000478	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—GNA11—ocular cancer	0.000466	0.000466	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—TP53—ocular cancer	0.000449	0.000449	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—E2F1—ocular cancer	0.000439	0.000439	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—GNAQ—ocular cancer	0.000433	0.000433	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—HRAS—ocular cancer	0.000429	0.000429	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—HDAC1—ocular cancer	0.00039	0.00039	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—AKT1—ocular cancer	0.000379	0.000379	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PSPH—ocular cancer	0.000324	0.000324	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—CDK2—ocular cancer	0.000277	0.000277	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MDM2—ocular cancer	0.000265	0.000265	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.000262	0.000262	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—HRAS—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CDKN1B—ocular cancer	0.000242	0.000242	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—AKT1—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CCND1—ocular cancer	0.000231	0.000231	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GNA11—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CDKN1A—ocular cancer	0.000223	0.000223	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—AKT1—ocular cancer	0.000217	0.000217	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EP300—ocular cancer	0.000213	0.000213	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GNAQ—ocular cancer	0.000209	0.000209	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GNA11—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—MYC—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TGFB1—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GNAQ—ocular cancer	0.000176	0.000176	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GNA11—ocular cancer	0.00017	0.00017	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GNAQ—ocular cancer	0.000158	0.000158	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—EP300—ocular cancer	0.000156	0.000156	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GNA11—ocular cancer	0.000155	0.000155	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TP53—ocular cancer	0.000152	0.000152	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—HRAS—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GNAQ—ocular cancer	0.000144	0.000144	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000142	0.000142	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TGFB1—ocular cancer	0.000135	0.000135	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—AKT1—ocular cancer	0.000128	0.000128	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000127	0.000127	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000116	0.000116	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TP53—ocular cancer	0.000111	0.000111	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—HRAS—ocular cancer	0.000107	0.000107	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GNA11—ocular cancer	0.000102	0.000102	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GNAQ—ocular cancer	9.48e-05	9.48e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—AKT1—ocular cancer	9.41e-05	9.41e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—EP300—ocular cancer	7.5e-05	7.5e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—EP300—ocular cancer	6.31e-05	6.31e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—EP300—ocular cancer	5.66e-05	5.66e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—EP300—ocular cancer	5.17e-05	5.17e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—AKT1—ocular cancer	4.53e-05	4.53e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—AKT1—ocular cancer	3.81e-05	3.81e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—AKT1—ocular cancer	3.42e-05	3.42e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—EP300—ocular cancer	3.41e-05	3.41e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—AKT1—ocular cancer	3.12e-05	3.12e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—AKT1—ocular cancer	2.06e-05	2.06e-05	CbGpPWpGaD
